Showing results (181-190 of 258) with videos related to

Sort By:
Pageof 26
Orphanet Journal of Rare Diseases|May 12, 2019
Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature reviewJames F H Pittaway, Christopher Harrison, Yumie Rhee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2021
Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled TrialAndrew Grey, Mark J Bolland, Anne Horne, et al.
Clinical Endocrinology|April 20, 2012
Pioglitazone in acromegaly - an open-label, prospective studyDavid D W Kim, Jovina Goh, Zaven Panossian, et al.
Orphanet Journal of Rare Diseases|April 6, 2018
Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature reviewJames F H Pittaway, Christopher Harrison, Yumie Rhee, et al.
Annals of Clinical Biochemistry|January 25, 2025
Biochemical osteomalacia in adults undergoing vitamin D testing in the North-East of ScotlandAngus D Macleod, Mark J Bolland, Andrew Balfour, et al.
Bonekey Reports|August 17, 2013
Subgroup analysis for the risk of cardiovascular disease with calcium supplementsLoretta T Radford, Mark J Bolland, Greg D Gamble, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal womenAndrew Grey, Mark J Bolland, Diana Wattie, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 10, 2016
Changing perceptions and efficacy of generic medicines: An intervention studySarah L E Colgan, Kate Faasse, Jennifer A Pereira, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2005
Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiencyAndrew Grey, Jenny Lucas, Anne Horne, et al.
Pageof 26